Answers are grounded in this paper and cite their sources.
As noted by others (Parfitt JR, Jayakumar S, Driman DK. Am J Surg Pathol. 2008; 32:1367-1372), mycophenolate mofetil-associated injury of the upper GI tract, like that in the colon, is characterized by prominent apoptosis similar to that of mild or grade I graft-versus-host-disease injury. We offer apoptotic count guidelines, which we hope will facilitate recognition of mycophenolate mofetil-associated injury in the upper GI tract.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: